BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 8625070)

  • 21. [Role of computerized tomography in the evaluation of extraductal extension of hilar cholangiocarcinoma].
    Frola C; Loria F; De Renzis C; Frosina P; Loria G; Panetta M; Cantoni S
    Radiol Med; 1994; 88(1-2):63-7. PubMed ID: 8066257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A proposal of imaging classification of intrahepatic mass-forming cholangiocarcinoma into ductal and parenchymal types: clinicopathologic significance.
    Rhee H; Kim MJ; Park YN; An C
    Eur Radiol; 2019 Jun; 29(6):3111-3121. PubMed ID: 30560357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pathology of gallbladder and extrahepatic bile ducts. Case 6. Well- differentiated hilar cholangiocarcinoma pT2bN1].
    Guettier C
    Ann Pathol; 2014 Aug; 34(4):309-14. PubMed ID: 25132442
    [No Abstract]   [Full Text] [Related]  

  • 24. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
    Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V
    Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phenotypic diversity of intrahepatic and extrahepatic cholangiocarcinoma on aspiration cytology and core needle biopsy: case series and review of the literature.
    Chaudhary HB; Bhanot P; Logroño R
    Cancer; 2005 Aug; 105(4):220-8. PubMed ID: 15952192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinicopathologic characteristics of intrahepatic cholangiocarcinoma in patients with positive serum a-fetoprotein.
    Zhou YM; Yang JM; Li B; Yin ZF; Xu F; Wang B; Liu P; Li ZM
    World J Gastroenterol; 2008 Apr; 14(14):2251-4. PubMed ID: 18407604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatic resection for intrahepatic cholangiocarcinoma: relation to gross tumor morphology.
    Itamoto T; Asahara T; Katayama K; Nakahara H; Fukuda T; Yano M; Hino H; Nakahara M; Dohi K; Shimamoto F
    Hepatogastroenterology; 2001; 48(40):1129-33. PubMed ID: 11490816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinicopathological characteristics of 15 patients with combined hepatocellular carcinoma and cholangiocarcinoma.
    Zuo HQ; Yan LN; Zeng Y; Yang JY; Luo HZ; Liu JW; Zhou LX
    Hepatobiliary Pancreat Dis Int; 2007 Apr; 6(2):161-5. PubMed ID: 17374575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intrahepatic cholangiocarcinoma associated with hepatolithiasis.
    Sato M; Watanabe Y; Ueda S; Ohno J; Kashu Y; Nezu K; Kawachi K
    Hepatogastroenterology; 1998; 45(19):137-44. PubMed ID: 9496503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term survival after extended surgical resection of intrahepatic cholangiocarcinoma with extensive lymph node metastasis.
    Asakura H; Ohtsuka M; Ito H; Kimura F; Ambiru S; Shimizu H; Togawa A; Yoshidome H; Kato A; Miyazaki M
    Hepatogastroenterology; 2005; 52(63):722-4. PubMed ID: 15966191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Application of Joint Detection of AFP, CA19-9, CA125 and CEA in Identification and Diagnosis of Cholangiocarcinoma.
    Li Y; Li DJ; Chen J; Liu W; Li JW; Jiang P; Zhao X; Guo F; Li XW; Wang SG
    Asian Pac J Cancer Prev; 2015; 16(8):3451-5. PubMed ID: 25921161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of combined hepatocellular and cholangiocarcinoma with hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
    Lee WS; Lee KW; Heo JS; Kim SJ; Choi SH; Kim YI; Joh JW
    Surg Today; 2006; 36(10):892-7. PubMed ID: 16998683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiologic spectrum of cholangiocarcinoma: emphasis on unusual manifestations and differential diagnoses.
    Lee WJ; Lim HK; Jang KM; Kim SH; Lee SJ; Lim JH; Choo IW
    Radiographics; 2001 Oct; 21 Spec No():S97-S116. PubMed ID: 11598251
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cholangiocarcinoma in a 24-year-old woman with hepatolithiasis.
    Leelawat K; Wannaprasert J
    J Med Assoc Thai; 2009 Jul; 92(7):983-6. PubMed ID: 19626820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proposal of progression model for intrahepatic cholangiocarcinoma: clinicopathologic differences between hilar type and peripheral type.
    Aishima S; Kuroda Y; Nishihara Y; Iguchi T; Taguchi K; Taketomi A; Maehara Y; Tsuneyoshi M
    Am J Surg Pathol; 2007 Jul; 31(7):1059-67. PubMed ID: 17592273
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic factors of intrahepatic cholangiocarcinoma after hepatic resection: univariate and multivariate analysis.
    Hanazaki K; Kajikawa S; Shimozawa N; Shimada K; Hiraguri M; Koide N; Adachi W; Amano J
    Hepatogastroenterology; 2002; 49(44):311-6. PubMed ID: 11995440
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Left hepatic trisegmentectomy for intraductal papillary cholangiocarcinoma: report of a case.
    Yamamoto M; Watayo T; Endoh A; Fujii M; Ida M; Kurisu Y; Takahashi M; Shibata M; Takasaki K
    Hepatogastroenterology; 1999; 46(30):3087-90. PubMed ID: 10626166
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intrahepatic cholangiocarcinoma arising in chronic advanced liver disease and the cholangiocarcinomatous component of hepatocellular cholangiocarcinoma share common phenotypes and cholangiocarcinogenesis.
    Xu J; Sasaki M; Harada K; Sato Y; Ikeda H; Kim JH; Yu E; Nakanuma Y
    Histopathology; 2011 Dec; 59(6):1090-9. PubMed ID: 22175889
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictive factors for intrahepatic cholangiocarcinoma recurrence in the liver following surgery.
    Miwa S; Miyagawa S; Kobayashi A; Akahane Y; Nakata T; Mihara M; Kusama K; Soeda J; Ogawa S
    J Gastroenterol; 2006 Sep; 41(9):893-900. PubMed ID: 17048054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The utility of keratin 903 as a new prognostic marker in mass-forming-type intrahepatic cholangiocarcinoma.
    Aishima S; Asayama Y; Taguchi K; Sugimachi K; Shirabe K; Shimada M; Sugimachi K; Tsuneyoshi M
    Mod Pathol; 2002 Nov; 15(11):1181-90. PubMed ID: 12429797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.